Uniphar Share Price, News & Analysis (LON:UPR) GBX 185 0.00 (0.00%) (As of 12/4/2023 ET) Add Compare Share Share Today's Range 185▼ 18850-Day Range 180▼ 21852-Week Range 178▼ 334Volume5,257 shsAverage Volume29,755 shsMarket Capitalization£505.09 millionP/E Ratio1,321.43Dividend Yield1.08%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades About Uniphar Stock (LON:UPR)Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, and internationally. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers; and distribution and support services to medical device manufacturers. The Product Access division provides on demand services, which offers access to pharmaco-medical products and treatments by developing valuable relationships and interactions between manufacturers and other healthcare stakeholders; and exclusive access services that provides bespoke distribution partnerships to pharmaceutical partners for key brands. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey's brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, data intelligence and consultancy services, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as data solutions for pharma industry. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.Read More UPR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart UPR Stock News HeadlinesNovember 20, 2023 | lse.co.ukUniphar Plc Share Price (UPR.IE)December 5, 2022 | finance.yahoo.comEdited Transcript of UPR.I earnings conference call or presentation 30-Aug-22 8:00am GMTDecember 4, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.October 16, 2022 | finance.yahoo.comUniphar plc (UPR.L)September 25, 2022 | marketwatch.comUnsaturated Polyester Resins (UPR) Market 2022 : Future Developments, Key Vendors, Regional Analysis and Industry Scope by 2027September 6, 2022 | barrons.comUniphar PLCSeptember 1, 2022 | proactiveinvestors.com.auFTSE 100 closes lower again as pound scrapes long-term lowsJuly 19, 2022 | investing.comUniphar Group PLC (UPR)December 4, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.August 21, 2021 | proactiveinvestors.comUniphar PLC - Holding(s) in CompanyJuly 29, 2021 | markets.businessinsider.comUniphar PLC : Half Year Trading Update and Notice of ResultsJuly 23, 2021 | markets.businessinsider.comUniphar PLC : Acquisition of CoRRect Medical GmbHJuly 20, 2021 | venturebeat.comMedTech VC Firm 415 CAPITAL Announces Strategic Alliance With European Healthcare Service Provider Uniphar Group PLCFebruary 2, 2021 | lse.co.ukBlackfinch Spr. Regulatory NewsNovember 23, 2020 | finance.yahoo.comWhat Is Uniphar's (ISE:UPR) P/E Ratio After Its Share Price Rocketed?See More Headlines Receive UPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Uniphar and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 10/20 Dividend9/28/2023Dividend Payable10/20/2023Today12/04/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Medical Distribution Sub-IndustryN/A SectorMedical Current SymbolLON:UPR CUSIPN/A CIKN/A Webwww.uniphar.ie Phone353 1 428 7777FaxN/AEmployees2,800Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.14 Trailing P/E Ratio1,321.43 Forward P/E Ratio10.36 P/E GrowthN/ANet Income£44.54 million Net Margins1.92% Pretax MarginN/A Return on Equity16.89% Return on Assets4.24% Debt Debt-to-Equity Ratio122.49 Current Ratio0.95 Quick Ratio0.60 Sales & Book Value Annual Sales£2.32 billion Price / Sales0.22 Cash FlowGBX 18.56 per share Price / Cash Flow9.97 Book ValueGBX 111 per share Price / Book1.67Miscellaneous Outstanding Shares273,020,000Free FloatN/AMarket Cap£505.09 million OptionableNot Optionable Beta0.73 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Gerard Rabbette B.Comm FCACEO & Executive DirectorMr. Timothy Dolphin B.Comm FCACFO & Executive DirectorMr. Allan Smylie C.F.A.Head of Strategy and Investor RelationsMs. Aisling McCarthyGeneral Counsel & Company SecretaryMr. Seamus EganHead of Corporate DevelopmentMr. Padraic DempseyChief Commercial OfficerMr. Brian O'ShaughnessyCCO and Commercial Lead of C&C Pharma & Product AccessMr. Dermot RyanManaging DirectorMs. Kay BonavitaChief Commercial Officer for Uniphar LogisticsRick HughesManaging Director of Uniphar LogisticsMore ExecutivesKey CompetitorsConsort Medical plc (CSRT.L)LON:CSRTSilence TherapeuticsLON:SLNAmryt PharmaLON:AMYTAdvanced Medical Solutions GroupLON:AMSPureTech HealthLON:PRTCView All Competitors UPR Stock Analysis - Frequently Asked Questions Should I buy or sell Uniphar stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Uniphar in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" UPR shares. View UPR analyst ratings or view top-rated stocks. How have UPR shares performed in 2023? Uniphar's stock was trading at GBX 267.50 at the beginning of 2023. Since then, UPR stock has decreased by 30.8% and is now trading at GBX 185. View the best growth stocks for 2023 here. How often does Uniphar pay dividends? What is the dividend yield for Uniphar? Uniphar announced a dividend on Thursday, September 14th. Stockholders of record on Thursday, September 28th will be paid a dividend of GBX 0.01 per share on Friday, October 20th. This represents a yield of 0.24%. The ex-dividend date of this dividend is Thursday, September 28th. The official announcement can be seen at this link. Read our dividend analysis for UPR. Is Uniphar a good dividend stock? Uniphar (LON:UPR) pays an annual dividend of GBX 2 per share and currently has a dividend yield of 0.82%. The dividend payout ratio is 1,428.57%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for UPR. How do I buy shares of Uniphar? Shares of UPR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:UPR) was last updated on 12/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Uniphar plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.